Amethyst Radiotherapy Uk Achieves Remarkable Four Year 84% Patient Growth
Amethyst Radiotherapy UK is proud to announce an impressive 84% growth in the number of patients annually treated in 2024, compared to 2020 when Amethyst Healthcare acquired the network.
Amethyst Radiotherapy Uk Achieves Remarkable Four Year 84% Patient Growth
Amethyst Radiotherapy UK is proud to announce an impressive 84% growth in the number of patients annually treated in 2024, compared to 2020 when Amethyst Healthcare acquired the network. This development includes a 70.1% increase in NHS patients, underscoring Amethyst’s commitment to work in partnership with the health service in order to deliver the highest quality of cancer care, driving down waiting times and improving patient outcomes.
Amethyst UK operates two stereotactic ‘centres of excellence’, in London and Sheffield. Both dedicated to delivering state-of-the-art Gamma Knife treatment. Gamma Knife is not a knife in the normal sense of the word. No incisions are made in the patient’s head. Instead, very precisely focused beams of radiation are directed to the treatment area in the brain, optimised to hit only the target while preserving healthy tissue.
It offers a safe and effective treatment for more than 80,000 patients worldwide every year. The treatment procedure is simple and straightforward.
Sophie Ward, Group Chief Marketing Officer, commented:
“We are thrilled to see such robust growth in the number of patients we’ve been able to treat over the past four years. This is a testament to the work of the entire Amethyst team, which has enabled such a huge number of patients to benefit from our world-leading services.
With the NHS under such intense pressure, we stand ready to provide further support if necessary in order to drive down waiting times and provide for patients.
To deliver this growth throughout such a challenging period including the COVID pandemic, speaks volumes about what Amethyst is capable of providing. We look forward to building on this success, benefiting both NHS and private patients.”
Looking ahead, Amethyst Radiotherapy UK plans to expand its capabilities and enhance its service offerings to meet the growing demand for cancer care. The company’s vision includes partnerships with NHS trusts and private healthcare providers to ensure that patients receive timely and effective treatment.
About Amethyst Radiotherapy UK Amethyst Radiotherapy is a leading provider of advanced radiotherapy services, dedicated to delivering world-class cancer care. With a focus on innovative treatment solutions and compassionate care, Amethyst strives to improve the quality of life for patients across the UK and beyond.
Amethyst Healthcare is a leading European provider of cancer care, specialising in radiation therapy and non-invasive outpatient treatments for a wide range of tumour types.
Centres of Excellence for Stereotactic Radiosurgery treatment of complex Brain Tumours
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!